article thumbnail

TGA – Australia: Independent Expert Panel on MDMA and psilocybin – Systematic literature review of the therapeutic value, benefits and risks of MDMA and psilocybin for the treatment of mental health conditions

Cannabis Law Report

Systematic literature review of the therapeutic value, benefits and risks of MDMA and psilocybin for the treatment of mental health conditions. An evaluation of the therapeutic value, benefits and risks of methylenedioxymethamphetamine (MDMA) and psilocybin for the treatment of mental, behavioural or developmental disorders.

article thumbnail

MS patients are being ‘denied’ access to NHS Sativex Says Media Report

Cannabis Law Report

Many are finding that despite the treatment being approved, they are being denied access in their area.”. The charity found that out of 106 clinical commissioning groups in England, only 49 were routinely offering cannabis based treatment. I can’t function and rely on other people to help with things like cooking and showering.

Access 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Three Major Australian Medical Cannabis Companies Fined By The TGA “over claims prescriptions could treat conditions such as cancer and epilepsy”

Cannabis Law Report

Australia’s drugs regulator issues 73 infringement notices over claims prescriptions could treat conditions such as cancer and epilepsy. The infringements were for the alleged unlawful advertising of medicinal cannabis products on websites and social media platforms. The Guardian reports. Cannatrek Ltd (22 notices, $293,040) and.

article thumbnail

MedXtractor Fills a Key Gap in Mental Health Treatments

Cannabis Law Report

Yet, despite nearly two billion people with mental illness each year, these conditions are routinely misdiagnosed and inadequately treated. In addition, the company aims to predict what treatments are most effective in addressing these conditions, including psychedelics, which have shown tremendous promise in early clinical trials.

article thumbnail

BetterLife Files Patent for TD-0148A for Treatment of Cluster Headaches and Related Disorders

Cannabis Law Report

We are excited to be developing and bringing to market treatments addressing cluster headaches, neuropathic pain and range of mental health conditions, including depression, anxiety and PTSD, and related disorders.”. Media Inquiries: Buchanan. billion industry by 2027. About BetterLife Pharma. BetterLife Pharma Inc.

article thumbnail

Czech Republic softens regulations on medical cannabis says media report

Cannabis Law Report

The Czech Republic legalized therapeutic cannabis for selected patients in 2015, and health insurance companies have been covering up to 90% of the cost of the treatment since 2020. According to official data cited by the Czech News Agency (CTK), the treatment helped improve the health condition and well-being of patients in 69% of cases.

Media 52
article thumbnail

PA: Court orders release on medical cannabis data regarding, “how many medical marijuana patients have received approval from a doctor to use cannabis for opioid addiction treatment.”

Cannabis Law Report

A panel of Commonwealth Court judges has ordered the Wolf administration to reveal how many medical marijuana patients have received approval from a doctor to use cannabis for opioid addiction treatment. Qualifying conditions include anxiety disorders, severe chronic pain and epilepsy.

Data 52